Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis

Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis

BackgroundDespite the lack of randomized-controlled trials in patients with failed bioprosthetic valves, valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) is increasingly used.MethodsOutcomes of consecutive patients treated with ViV-TAVR (N = 100) at our tertiary heart center between...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Paukovitsch, Bartu Dilaver, Dominik Felbel, Marvin Krohn-Grimberghe, Dominik Buckert, Johannes Moerike, Leonhard Moritz Schneider, Christian Liewald, Wolfgang Rottbauer, Birgid Gonska
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
valve in valve aortic replacement
bioprosthetic valve degeneration
transcatheter aortic replacement
device success
bioprosthetic valve failure
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1465409/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2025.1465409/full

Similar Items